KangaBio
Latest round
- Angel
Last raised
- Dec 2021
Total raised
- Undisclosed
Investors
- 1
About KangaBio
Established in 2021 and based in Shanghai, China, KangaBio is a biotechnology company focused on providing innovative medicines to meet unmet clinical medical needs. The company's founder and CEO, Dr. Weidong Jiang, previously co-founded Shanghai Fohong Hanlin Biotechnology Co. in 2009, which led to its successful listing on the Hong Kong Stock Exchange in 2019. Currently, the company has formed R&D teams in the direction of protein drug early discovery and drug process development, etc. The company focuses on the development of safe and effective oncology drugs to meet unmet clinical needs in oncology therapeutic areas by developing a new generation of immune agonists and multi-specific antibodies based on globally innovative prodrug protein molecular technologies. Its current pipeline includes KGX101, a modified and optimized cytokine IL12 prodrug molecule, and KGX103, a cytokine prodrug molecule targeted to treat solid and metastatic tumors, etc.
Who invested in KangaBio
1 investor across 1 round
See all investors in KangaBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Dec 31, 2021
Amount
Undisclosed
Investors
Questions about KangaBio
Who invested in KangaBio?
KangaBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KangaBio raised?
KangaBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KangaBio last raise money?
KangaBio's most recent round on record is a Angel, in Dec 2021.
What does KangaBio do?
Established in 2021 and based in Shanghai, China, KangaBio is a biotechnology company focused on providing innovative medicines to meet unmet clinical medical needs.
Where is KangaBio headquartered?
KangaBio is headquartered in Shanghai, China.
Which VCs invest in companies like KangaBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at KangaBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like KangaBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.